Medicamen Organics Limited IPO
Medicamen Organics Limited is an NSE SME IPO listed on the NSE SME platform, priced at ₹32–₹34 per share. The stock debuted at ₹137.85, delivering a listing gain of 305.4%. The IPO had a lot size of ₹4000 shares and a minimum investment of ₹1,36,000.
Medicamen Organics Limited IPO
- IPO Dates
- Jun 21, 2024 – Jun 25, 2024
- Price band
- ₹32-34 per equity share
- Minimum Investment
- ₹1,36,000
- Issue size
- ₹10.54 Cr
- Lot size
- 4000
- Allotment Date
- Jun 26, 2024
- Listing
- Jun 28, 2024
- Listing At
- NSE SME
IPO timeline
-
Jun 21, 2024
Open Date
Completed
-
Jun 25, 2024
Close Date
Completed
-
Jun 26, 2024
Allotment Date
Completed
-
Jun 28, 2024
Listing Date
Completed
Medicamen Organics Limited IPO Essentials
Medicamen Organics Limited IPO Details
Medicamen Organics Limited IPO is priced at ₹32-34 per share with a total issue size of 10.54 crore. The IPO has a lot size of 4000 shares and is listed on NSE SME.
- Issue price
- ₹32-34 per equity share
- Lot size
- 4000 shares
- Face value
- ₹10 Per Equity Share
- Issue size
- 3,100,000 shares(aggregating up to ₹10.54 Cr)
- Total issue size
- 31,00,000 shares
(aggregating up to ₹10.54 crore) - Fresh issue
- 31,00,000 shares
(aggregating up to ₹10.54 crore) - Listing at
- NSE SME
- List price
- 137.85
- Listing date
- Registrar
- Kfin Technologies Limited
- Lead manager
-
GYR Capital Advisors Private Limited
Market Lot Size
Investors can bid for a minimum of 4000 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Retail Investors and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (min) | 1 | 4000 | ₹1,36,000 |
| Retail(max) | 1 | 4000 | ₹1,36,000 |
| NII (min) | 2 | 8,000 | ₹2,72,000 |
Medicamen Organics Limited IPO Reservation
Medicamen Organics Limited IPO reservation details show category-wise allocation of shares. Out of the total 3,100,000 shares, approximately 18.84% are reserved for QIB, 14.19% for NII, 33.16% for retail investors, 5.55% for market maker, and 28.26% for anchor investors.
| Investor Category | Shares Offered | Maximum Allottees |
|---|---|---|
| Anchor Investor Shares Offered | 876,000 (28.26%) | |
| Market Maker Shares Offered | 172,000 (5.55%) | |
| QIB Shares Offered | 584,000 (18.84%) | |
| NII (HNI) Shares Offered | 440,000 (14.19%) | |
| Retail Shares Offered | 1,028,000 (33.16%) | |
| Total Shares Offered | 3,100,000 (100%) |
Medicamen Organics Limited IPO Analytics
Medicamen Organics Limited IPO category-wise subscription trends show day-wise participation across QIB, NII, and retail investors.
Medicamen Organics Limited IPO Subscription Status
Medicamen Organics Limited IPO subscription status shows demand across retail, NII, and QIB categories, helping investors understand overall participation trends.
The IPO subscription status indicates investor demand across categories.
| As on | QIB / NII | Retail | Total |
|---|---|---|---|
| Shares Offered / Reserved | 584,000 / 440,000 | 1,028,000 | 2,052,000 |
|
Day 1
21-06-24 06:00 PM
|
(1.01 / 37.20) x | 92.26 x | 54.49 x |
|
Day 2
24-06-24 06:00 PM
|
(1.42 / 125.83) x | 348.14 x | 201.79 x |
|
Day 3
25-06-24 06:00 PM
|
(173.03 / 1344.22) x | 1309.77 x | 993.64 x |
Medicamen Organics Limited Valuations
Earnings
- EPS Pre IPO
- ₹1.11/-
- EPS Post IPO
- ₹2.21/-
- P/E Pre IPO
- 30.53
- P/E Post IPO
- 15.41
Returns
- ROE
- 19.90%
- ROCE
- 14.50%
- RoNW
- 15.83%
- PAT Margin
- 9.51
Fundamentals
- Debt / Equity
- 0.83
- Price / Book
- 2.39
Medicamen Organics Limited Financials( In Lakhs)
| 31-Mar-24 | 31-Mar-23 | 31-Mar-22 | |
|---|---|---|---|
| Assets | 3,858.07 | 3,211.98 | 2,707.21 |
| Revenue | 2,528.96 | 2,296.24 | 2,118.67 |
| Profit After Tax | 240.41 | 95.78 | 9.23 |
| Net Worth | 1,518.40 | 851.71 | 755.92 |
| Reserves & Surplus | 658.40 | 251.71 | 155.92 |
| Total Borrowing | 1,265.65 | 1,179.50 | 1,024.57 |
Medicamen Organics Limited Company & Offer Insights
About Medicamen Organics Limited
Medicamen Organics Limited was established in 1995 and engages in the development, manufacture, and marketing of pharmaceutical dosages, including generic dosages, in the form of tablets, capsules, oral liquids, ointments, gels, syrups, suspensions, and dry powders to the Government (State Governments and Central Governments) and private parties as a contract manufacturer/third-party manufacturer.
The company's product list includes 84 products and a wide range of drugs such as antibacterial, antidiarrheal, antifungal, antimalarial, antidiabetic, proton pump inhibitors, antihistamines, antihypertensive drugs, lipid preparations, antiparasitics, multivitamin preparations, multimineral and non-steroidal anti-inflammatory drugs (NSAIDS).
The company sells its products all over India as well as in African, CIS, and South East Asian countries such as Congo, Benin, Kameg, Togo, Senegal, Burkina Faso, Philippines, Myanmar, Mozambique, Togo, Burundi, Kyrgyzstan and Kenya through third-party distributors.
There are two WHO-GMP compliant manufacturing plants covering 21,536 Sq. Ft of Haridwar in Uttarakhand. By the date September 30, 2023, it entered a contract with manufacturing deals at domestic end through 38 companies and had the number of Merchant exporters totaling at 12 entities.
As of September 30, 2023, the total number of people employed by the company is 116.
Medicamen Organics Limited Promoter(s)
Mr. Bal Kishan Gupta are the company's promoters of Medicamen Organics Limited.
Medicamen Organics Limited IPO Issue Objectives
- •
- Funding of expenses proposed to be incurred towards Product registration in the international markets
- •
- Plant updation and increase in production capacity
- •
- Funding working capital requirements of our Company
- •
- General Corporate Purposes.
Medicamen Organics Limited IPO - Peers Comparison
| Company Name | EPS (Basic) | EPS (Diluted) | NAV (per share) (Rs) | P/E (x) | RoNW (%) | P/BV Ratio | Financial statements |
|---|---|---|---|---|---|---|---|
| Medicamen Organics Limited | 3.18 | 3.18 | 17.66 | N/A | 15.83 | 1.93 | Restated Financial Statement |
| Brooks Laboratories Ltd. | -12.57 | -12.57 | 30.1 | 10.6 | -28.26 | 4.43 | Standalone Financial Statement |
| Cian Healthcare Ltd | 0.43 | 0.43 | 22.4 | 53.84 | 1.75 | 1.03 | Standalone Financial Statement |
| Zenotech Laboratories Ltd. | 1.9 | 1.9 | 14.2 | 38.76 | 14.08 | 5.19 | Standalone Financial Statement |
Notes:
- NAV per share is computed as the closing net worth divided by the weighted average number of paid-up equity shares as on March 31, 2024.
- RoNW has been computed as net profit after tax divided by closing net worth.
- Net worth has been computed in the manner as specified in Regulation 2(1)(hh) of SEBI (ICDR) Regulations, 2018.
Contact Information
Contact Details
Medicamen Organics Limited
+91-9818222845
http://www.medicamenorganics.com/
10 Community Centre,, No 2 Ashok Vihar Phase II, New Delhi, Delhi, 110052
Registrar Contact Details
Kfin Technologies Limited
04067162222, 04079611000
Frequently Asked Questions
Click any question to reveal the answer
Medicamen Organics Limited IPO is a book-built IPO worth ₹10.54 crore. The price band is ₹32–₹34 per share. The IPO opens on Jun 21, 2024 and closes on Jun 25, 2024. It will be listed on NSE SME Platform. Kfin Technologies Limited is the registrar.
The price band of Medicamen Organics Limited IPO is ₹32 to ₹34 per share.
The lot size of Medicamen Organics Limited IPO is 4000 shares.
The minimum investment for Medicamen Organics Limited IPO is approximately ₹1,36,000 based on the upper price band .
Medicamen Organics Limited IPO opens on Jun 21, 2024 and closes on Jun 25, 2024.
The allotment date of Medicamen Organics Limited IPO is Jun 26, 2024.
Medicamen Organics Limited IPO is expected to be listed on Jun 28, 2024, on NSE SME Platform.
Medicamen Organics Limited IPO valuation snapshot: P/E 15.41, EPS ₹2.21/-, P/B 2.39, RoNW 15.83%, and market cap N/A.
To apply for Medicamen Organics Limited IPO, open the IPO Ji app or website, select the IPO, choose your demat account, enter the quantity, and submit the application.
You can check the live subscription status of Medicamen Organics Limited IPO on IPO Ji or stock exchange websites. It shows real-time demand across retail, NII, and QIB categories.
Pre-apply allows investors to submit their IPO application before the bidding period starts. The order is placed automatically when the IPO opens.
If you pre-apply for Medicamen Organics Limited IPO, your order will be placed when the IPO bidding starts, and a UPI mandate request will be generated.
You can check Medicamen Organics Limited IPO allotment status on the registrar or stock exchange websites using your PAN or application number after allotment. You can also check the Medicamen Organics Limited IPO allotment status on IPO Ji for quick and easy access.